First biologic therapy for young children with severe eczema
Drug Discovery World
SEPTEMBER 16, 2022
A biologic therapy for very young children with moderate to severe eczema (or atopic dermatitis) has been shown to be safe and effective in an international trial. The therapy is already licensed in the UK for adults and children aged six to 18, and was approved by the FDA in June 2022 for use in younger children.
Let's personalize your content